Hazard ratio (95% CI) | P value | |
---|---|---|
PFS | ||
Stage (IV vs IIIA/IIIB) | 1.838 (0.918–3.680) | 0.086 |
CD14+CD11b+CD33+CD15+HLA-DR−Lin− (above vs below 90% of controls) | 2.408 (1.368–4.241) | 0.002 |
OS | ||
CD14+CD11b+CD33+CD15+HLA-DR−Lin− (above vs below 90% of controls) | 2.349 (1.252–4.407) | 0.008 |